Amphenol Corp (APH)

Amphenol Announces Pricing of Euro-Denominated Senior Notes OfferingsMay 5, 2026 4:59 PM
Business Wire Amphenol Corporation (NYSE: APH) (the “Company”) announced today the pricing of its offering of €600 million aggregate principal amount of senior notes due 2029 (the “2029 Notes”) and €500 million aggregate principal amount of senior notes due 2034 (the “2034 Notes” and, together with the 2029 Notes, the “Notes”). The 2029 Notes will have an interest rate of 3.375% per annum, and the 2034 Notes will have an interest rate of 3.875% per annum. The closing of the offering of the Notes (the “Notes Offering”) is expected to occur on May 12, 2026, subject to the satisfaction of customary closing conditions. The Company intends to use the net proceeds from the Notes Offering to repay borrowings under its U.S. commercial paper program and 364-day unsecured delayed draw term loan credit agreement, and for general corporate purposes. Barclays Bank PLC, Citigroup Global Markets Limited, Commerzbank Aktiengesellschaft and HSBC Bank plc are serving as the joint book-running managers for the Notes Offering. The Notes are being offered pursuant to the Company’s effective shelf registration statement on file with the Securities and Exchange Commission (the “SEC”). A prospectus supplement describing the terms of the Notes Offering will be filed with the SEC. Copies of the prospectus supplement and accompanying prospectus for the Notes Offering may be obtained from Barclays Bank PLC toll-free at 1-888-603-5847, Citigroup Global Markets Limited toll-free at 1-800-831-9146, Commerzbank Aktiengesellschaft toll-free at 1-800-233-9164 or HSBC Bank plc toll-free at 1-866-811-8049. This press release does not constitute an offer to sell or the solicitation of an offer to buy the Notes, nor will there be any sale of the Notes, in any jurisdiction in which such offer, solicitation or sale would be unlawful. Any offer, solicitation or sale of the Notes will be made only by means of the prospectus supplement and the accompanying prospectus. About Amphenol Amphenol Corporation is one of the world’s largest designers, manufacturers and marketers of electrical, electronic and fiber optic connectors and interconnect systems, antennas, sensors and sensor-based products and coaxial, high-speed, fiber optic and specialty cable. Amphenol designs, manufactures and assembles its products at facilities in approximately 40 countries around the world and sells its products through its own global sales force, independent representatives and a global network of electronics distributors. Amphenol has a diversified presence as a leader in high-growth areas of the interconnect market including: Automotive, Commercial Aerospace, Communications Networks, Defense, Industrial, Information Technology and Data Communications and Mobile Devices. For more information, visit www.amphenol.com. Forward-Looking Statements Statements in this press release which are other than historical facts are intended to be “forward-looking statements” within the meaning of the Securities Exchange Act of 1934, as amended, the Private Securities Litigation Reform Act of 1995 and other related laws. While the Company believes such statements are reasonable, the actual results and effects could differ materially from those currently anticipated. Details regarding various significant risks and uncertainties that may affect the Company’s operating and financial performance can be found in the Company’s latest Annual Report on Form 10-K and the Company’s subsequent filings with the Securities and Exchange Commission, including Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. In providing forward-looking statements, the Company is not undertaking any duty or obligation to update these statements publicly as a result of new information, future events or otherwise, except as required by law. Prohibition of Sales to EEA Retail Investors The Notes are not intended to be offered, sold or otherwise made available, and should not be offered, sold or otherwise made available, to any retail investor in the European Economic Area (the “EEA”). For these purposes, a retail investor means a person who is one (or more) of: (i) a retail client as defined in point (11) of Article 4(1) of Directive 2014/65/EU (as amended, “MiFID II”); (ii) a customer within the meaning of Directive (EU) 2016/97 (as amended, the “Insurance Distribution Directive”), where that customer would not qualify as a professional client as defined in point (10) of Article 4(1) of MiFID II; or (iii) not a qualified investor as defined in Regulation (EU) 2017/1129 (as amended, the “Prospectus Regulation”). Consequently, no key information document required by Regulation (EU) No 1286/2014 (as amended, the “PRIIPs Regulation”) for offering or selling the Notes or otherwise making them available to retail investors in the EEA has been prepared and therefore offering or selling the Notes or otherwise making them available to any retail investor in the EEA may be unlawful under the PRIIPs Regulation. Any offer of Notes in any Member State of the EEA will be made pursuant to an exemption under the Prospectus Regulation from the requirement to publish a prospectus for offers of Notes. The prospectus supplement and the accompanying prospectus relating to the issue of the Notes is not a prospectus for the purposes of the Prospectus Regulation. United Kingdom The communication of this announcement, the prospectus supplement, the accompanying prospectus, any related free writing prospectus and any other document or materials relating to the issue of the Notes is not being made, and such documents and/or materials have not been approved, by an authorized person for the purposes of section 21 of the United Kingdom’s Financial Services and Markets Act 2000 (as amended, the “FSMA”). Accordingly, such documents and/or materials are not being distributed to, and must not be passed on to, the general public in the United Kingdom (“UK”). The communication of such documents and/or materials is only being made to (i) persons outside the UK; (ii) and those persons in the UK (A) who have professional experience in matters relating to investments who fall within the definition of investment professionals (as defined in Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended, the “Financial Promotion Order”)); or (B) who are high net worth companies, or other persons to whom they may lawfully be communicated, falling within Article 49(2)(a) to (d) of the Financial Promotion Order, (all such persons together being referred to as “relevant persons”). In the UK, this announcement, the prospectus supplement, the accompanying prospectus and the Notes offered hereby are only available to, and any investment or investment activity to which this announcement, the prospectus supplement, the accompanying prospectus, any related free writing prospectus or any other document or materials relating to the issue of the Notes relates will be engaged in only with, relevant persons. Any person in the UK that is not a relevant person should not act or rely on this announcement, the prospectus supplement, the accompanying prospectus, any related free writing prospectus or any other document or materials relating to the issue of the Notes or any of their contents. Prohibition of Sales to UK Retail Investors The Notes are not intended to be offered, sold, distributed or otherwise made available to and should not be offered, sold, distributed or otherwise made available to any retail investor in the UK. For these purposes, a retail investor means a person who is either one (or both) of the following: (i) not a professional client, as defined in point (8) of Article 2(1) of Regulation (EU) No 600/2014 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018 (“EUWA”), or (ii) not a qualified investor as defined in paragraph 15 of Schedule 1 to the Public Offers and Admissions to Trading Regulation 2024 (“POATRs”). Consequently, no disclosure document required by the FCA Product Disclosure Sourcebook (“DISC”) for offering, selling or distributing the Notes or otherwise making them available to retail investors in the UK has been prepared and therefore offering, selling or distributing the Notes or otherwise making them available to any retail investor in the UK may be unlawful under DISC and the Consumer Composite Investments (Designated Activities) Regulations 2024 . Any offer of Notes in the UK will be made pursuant to an exception from the prohibition on offers to the public under the POATRs. UK MIFIR Product Governance / Professional Investors and ECPs Only Target Market Solely for the purposes of each manufacturer’s product approval process, the target market assessment in respect of the Notes has led to the conclusion that: (i) the target market for the Notes is only eligible counterparties as defined in the FCA Handbook Conduct of Business Sourcebook (“COBS”), and professional clients, as defined in Regulation (EU) No 600/2014 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018 (“UK MiFIR”); and (ii) all channels for distribution of the Notes to eligible counterparties and professional clients are appropriate. Any person subsequently offering, selling or recommending the Notes (a “distributor”) should take into consideration the manufacturers’ target market assessment; however, a distributor subject to the FCA Handbook Product Intervention and Product Governance Sourcebook (the “UK MiFIR Product Governance Rules”) is responsible for undertaking its own target market assessment in respect of the Notes (by either adopting or refining the manufacturers’ target market assessment) and determining appropriate distribution channels. MIFID II Product Governance / Professional Investors and ECPs Only Target Market Solely for the purposes of each manufacturer’s product approval process, the target market assessment in respect of the Notes has led to the conclusion that: (i) the target market for the Notes is eligible counterparties and professional clients only, each as defined in MiFID II; and (ii) all channels for distribution of the Notes to eligible counterparties and professional clients are appropriate. Any person subsequently offering, selling or recommending the Notes (a “distributor”) should take into consideration the manufacturers’ target market assessment; however, a distributor subject to MiFID II is responsible for undertaking its own target market assessment in respect of the Notes (by either adopting or refining the manufacturers’ target market assessment) and determining appropriate distribution channels. View source version on businesswire.com: https://www.businesswire.com/news/home/20260505927289/en/ Sherri Scribner
Vice President, Strategy and Investor Relations
203-265-8820
IR@amphenol.com Original: Amphenol Announces Pricing of Euro-Denominated Senior Notes Offerings

Amphenol Announces Pricing of Euro-Denominated Senior Notes OfferingMarch 24, 2026 4:15 PM
Business Wire
Amphenol Corporation (NYSE: APH) (the “Company”) announced today the pricing of an offering of €500 million aggregate principal amount of senior notes due 2031 (the “Notes”) to be issued by its wholly owned subsidiary Amphenol Technologies Holding GmbH (“Amphenol Technologies”), a German limited liability company (Gesellschaft mit beschränkter Haftung). The Notes will be guaranteed by the Company and will have an interest rate of 3.625% per annum. The closing of the offering of the Notes (the “Notes Offering”) is expected to occur on March 30, 2026, subject to the satisfaction of customary closing conditions.


Amphenol Technologies intends to use the net proceeds from the Notes Offering to repay Amphenol Technologies’ outstanding 0.750% Euro Senior Notes due 2026 at maturity and for general corporate purposes.


Barclays Bank PLC, Citigroup Global Markets Europe AG, Commerzbank Aktiengesellschaft and HSBC Bank plc are serving as the joint book-running managers for the Notes Offering.


The Notes are being offered pursuant to the Company’s effective shelf registration statement on file with the Securities and Exchange Commission (the “SEC”). A prospectus supplement describing the terms of the Notes Offering will be filed with the SEC. Copies of the prospectus supplement and accompanying prospectus for the Notes Offering may be obtained from Barclays Bank PLC toll-free at 1-888-603-5847, Citigroup Global Markets Europe AG toll-free at 1-800-831-9146, Commerzbank Aktiengesellschaft toll-free at 1-800-233-9164 or HSBC Bank plc toll-free at 1-866-811-8049.


This press release does not constitute an offer to sell or the solicitation of an offer to buy the Notes, nor will there be any sale of the Notes, in any jurisdiction in which such offer, solicitation or sale would be unlawful. Any offer, solicitation or sale of the Notes will be made only by means of the prospectus supplement and the accompanying prospectus.


About Amphenol

Amphenol Corporation is one of the world’s largest designers, manufacturers and marketers of electrical, electronic and fiber optic connectors and interconnect systems, antennas, sensors and sensor-based products and coaxial, high-speed, fiber optic and specialty cable. Amphenol designs, manufactures and assembles its products at facilities in approximately 40 countries around the world and sells its products through its own global sales force, independent representatives and a global network of electronics distributors. Amphenol has a diversified presence as a leader in high-growth areas of the interconnect market including: Automotive, Commercial Aerospace, Communications Networks, Defense, Industrial, Information Technology and Data Communications and Mobile Devices. For more information, visit www.amphenol.com.


Forward-looking Statements

Statements in this press release which are other than historical facts are intended to be “forward-looking statements” within the meaning of the Securities Exchange Act of 1934, as amended, the Private Securities Litigation Reform Act of 1995 and other related laws. While the Company and Amphenol Technologies believe such statements are reasonable, the actual results and effects could differ materially from those currently anticipated. Details regarding various significant risks and uncertainties that may affect the Company’s operating and financial performance can be found in the Company’s latest Annual Report on Form 10-K and the Company’s subsequent filings with the Securities and Exchange Commission, including Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. In providing forward-looking statements, the Company and Amphenol Technologies are not undertaking any duty or obligation to update these statements publicly as a result of new information, future events or otherwise, except as required by law.


Prohibition of Sales to EEA Retail Investors

The Notes are not intended to be offered, sold or otherwise made available, and should not be offered, sold or otherwise made available, to any retail investor in the European Economic Area (the “EEA”). For these purposes, a retail investor means a person who is one (or more) of: (i) a retail client as defined in point (11) of Article 4(1) of Directive 2014/65/EU (as amended, “MiFID II”); (ii) a customer within the meaning of Directive (EU) 2016/97 (as amended, the “Insurance Distribution Directive”), where that customer would not qualify as a professional client as defined in point (10) of Article 4(1) of MiFID II; or (iii) not a qualified investor as defined in Regulation (EU) 2017/1129 (as amended, the “Prospectus Regulation”). Consequently, no key information document required by Regulation (EU) No 1286/2014 (as amended, the “PRIIPs Regulation”) for offering or selling the Notes or otherwise making them available to retail investors in the EEA has been prepared and therefore offering or selling the Notes or otherwise making them available to any retail investor in the EEA may be unlawful under the PRIIPs Regulation. Any offer of Notes in any Member State of the EEA will be made pursuant to an exemption under the Prospectus Regulation from the requirement to publish a prospectus for offers of Notes. The prospectus supplement and the accompanying prospectus relating to the issue of the Notes is not a prospectus for the purposes of the Prospectus Regulation.


United Kingdom

The communication of this announcement, the prospectus supplement, the accompanying prospectus, any related free writing prospectus and any other document or materials relating to the issue of the Notes is not being made, and such documents and/or materials have not been approved, by an authorized person for the purposes of section 21 of the United Kingdom’s Financial Services and Markets Act 2000 (as amended, the “FSMA”). Accordingly, such documents and/or materials are not being distributed to, and must not be passed on to, the general public in the United Kingdom (“UK”). The communication of such documents and/or materials is only being made to (i) persons outside the UK; (ii) and those persons in the UK (A) who have professional experience in matters relating to investments who fall within the definition of investment professionals (as defined in Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended, the “Financial Promotion Order”)); or (B) who are high net worth companies, or other persons to whom they may lawfully be communicated, falling within Article 49(2)(a) to (d) of the Financial Promotion Order, (all such persons together being referred to as “relevant persons”). In the UK, this announcement, the prospectus supplement, the accompanying prospectus and the Notes offered hereby are only available to, and any investment or investment activity to which this announcement, the prospectus supplement, the accompanying prospectus, any related free writing prospectus or any other document or materials relating to the issue of the Notes relates will be engaged in only with, relevant persons. Any person in the UK that is not a relevant person should not act or rely on this announcement, the prospectus supplement, the accompanying prospectus, any related free writing prospectus or any other document or materials relating to the issue of the Notes or any of their contents.


Prohibition of Sales to UK Retail Investors

The Notes are not intended to be offered, sold or otherwise made available to and should not be offered, sold or otherwise made available to any retail investor in the UK. For these purposes, a retail investor means a person who is neither: (i) a professional client, as defined in point (8) of Article 2(1) of Regulation (EU) No 600/2014 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018 (“EUWA”), nor (ii) a qualified investor as defined in paragraph 15 of Schedule 1 to the Public Offers and Admissions to Trading Regulation 2024 (“POATRs”). Consequently, no key information document required by the PRIIPs Regulation as it forms part of domestic law by virtue of the EUWA (the “UK PRIIPs Regulation”) for offering or selling the Notes or otherwise making them available to retail investors in the UK has been prepared and therefore offering or selling the Notes or otherwise making them available to any retail investor in the UK may be unlawful under the UK PRIIPs Regulation. Any offer of Notes in the UK will be made pursuant to an exception from the prohibition on offers to the public under the POATRs.


UK MIFIR product governance / Professional Investors and ECPs Only Target Market

Solely for the purposes of each manufacturer’s product approval process, the target market assessment in respect of the Notes has led to the conclusion that: (i) the target market for the Notes is only eligible counterparties as defined in the FCA Handbook Conduct of Business Sourcebook (“COBS”), and professional clients, as defined in Regulation (EU) No 600/2014 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018 (“UK MiFIR”); and (ii) all channels for distribution of the Notes to eligible counterparties and professional clients are appropriate. Any person subsequently offering, selling or recommending the Notes (a “distributor”) should take into consideration the manufacturers’ target market assessment; however, a distributor subject to the FCA Handbook Product Intervention and Product Governance Sourcebook (the “UK MiFIR Product Governance Rules”) is responsible for undertaking its own target market assessment in respect of the Notes (by either adopting or refining the manufacturers’ target market assessment) and determining appropriate distribution channels.


MIFID II product governance / Professional investors and ECPs only target market

Solely for the purposes of each manufacturer’s product approval process, the target market assessment in respect of the Notes has led to the conclusion that: (i) the target market for the Notes is eligible counterparties and professional clients only, each as defined in MiFID II; and (ii) all channels for distribution of the Notes to eligible counterparties and professional clients are appropriate. Any person subsequently offering, selling or recommending the Notes (a “distributor”) should take into consideration the manufacturers’ target market assessment; however, a distributor subject to MiFID II is responsible for undertaking its own target market assessment in respect of the Notes (by either adopting or refining the manufacturers’ target market assessment) and determining appropriate distribution channels.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260324618606/en/
Sherri Scribner

Vice President, Strategy and Investor Relations

203-265-8820

IR@amphenol.com


Original: Amphenol Announces Pricing of Euro-Denominated Senior Notes Offering

NYSE Content Update: Boyd Group Services Rings Opening Bell to Celebrate Recent ListingFebruary 10, 2026 8:55 AM
PR Newswire (Canada)

NYSE issues a pre-market daily advisory direct from the trading floor.NEW YORK, Feb. 10, 2026 /CNW/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. 



Ashley Mastronardi delivers the pre-market update on February 10thEquities are little changed in extended trading hours Tuesday morning after the Dow Jones Industrial Average closed at a record on Monday.Resolve AI recently announced a $125 million Series A round of funding, elevating it to unicorn status.Chairman and CEO of Abacus Global Management, Jay Jackson, sat down with Lance Glinn on the Inside the ICE House podcast to celebrate its recent transfer to the NYSE.Canada-based Boyd Group Services at the NYSE to ring the opening bell.For market insights, IPO activity, and today's opening bell, download the NYSE TV app at tv.nyse.comOpening Bell
Boyd Group Services Inc (NYSE: BGSI) celebrates its recent listingClosing Bell
Amphenol Corporation (NYSE: APH) celebrates its 35th Anniversary of ListingClick here to download the NYSE TV App














View original content to download multimedia:https://www.prnewswire.com/news-releases/nyse-content-update-boyd-group-services-rings-opening-bell-to-celebrate-recent-listing-302683799.htmlSOURCE New York Stock Exchange

Original: NYSE Content Update: Boyd Group Services Rings Opening Bell to Celebrate Recent Listing

Amphenol Announces Board Succession PlanFebruary 4, 2026 4:44 PM
Business Wire
Amphenol Corporation (NYSE: APH) today announced that the Board of Directors has appointed R. Adam Norwitt, currently serving as President and Chief Executive Officer, to the additional role of Chairman of the Board, effective on the date of the Company’s 2026 Annual Meeting of Stockholders, which is expected to be in May 2026. After more than five decades with Amphenol, including serving as President from 1987 to 2006, Chief Executive Officer from 1996 to 2008 and as Chairman of the Board since 1997, Martin H. Loeffler intends to retire from the Board also effective in May. As part of this leadership transition, David P. Falck, who has served as a Director since 2013 and Presiding Director since 2016, will continue to serve as Lead Independent Director.


“On behalf of the Board of Directors, I want to thank Martin for his exceptional contributions to the Company over these many decades and express the Board’s deep appreciation for the outstanding results he has helped Amphenol to achieve,” said Mr. Falck. “The decision to appoint Adam as Amphenol’s Chairman reflects the Board’s confidence in his strong leadership as well as his deep industry experience and long-term strategic vision for the Company.”


“I am extremely pleased to recognize Adam’s unique contributions to Amphenol with his promotion to Chairman of the Board,” said Mr. Loeffler. “I would like to congratulate Adam on his extraordinary leadership so far as President and CEO and express my warmest wishes to him as he takes on this important additional role as Chairman. I have no doubt that Adam will continue to be an outstanding steward of Amphenol’s culture, while further supporting the superior growth and profitability of the Company.”


“I am deeply honored and humbled to be named Chairman of the Amphenol Board,” said Mr. Norwitt. “I want to offer my sincere thanks to Martin who has been an iconic leader in the interconnect industry. Nearly 40 years ago, Martin helped establish the foundation of Amphenol’s entrepreneurial culture and nurtured that culture through his roles as President, CEO and Chairman. This entrepreneurial culture has been the key enabler of Amphenol’s extraordinary growth and performance over these many years. On a personal note, I would also like to thank Martin for his invaluable mentorship and unwavering support during my career at Amphenol.”


About Amphenol

Amphenol Corporation is one of the world’s largest designers, manufacturers and marketers of electrical, electronic and fiber optic connectors and interconnect systems, antennas, sensors and sensor-based products and coaxial, high-speed, fiber optic and specialty cable. Amphenol designs, manufactures and assembles its products at facilities in approximately 40 countries around the world and sells its products through its own global sales force, independent representatives and a global network of electronics distributors. Amphenol has a diversified presence as a leader in high-growth areas of the interconnect market including: Automotive, Commercial Aerospace, Communications Networks, Defense, Industrial, Information Technology and Data Communications and Mobile Devices. For more information, visit www.amphenol.com.


Forward-looking Statements

Statements in this press release, other than historical facts, are intended to be “forward looking statements” within the meaning of the Securities Exchange Act of 1934, the Private Securities Litigation Reform Act of 1995 and other related laws. While the Company believes such statements are reasonable, the actual results and effects could differ materially from those currently anticipated. Please refer to Part I, Item 1A of the Company’s Annual Report on Form 10-K for the year ended December 31, 2024, for factors that could cause actual results to differ from estimates. In providing forward-looking statements, the Company is not undertaking any duty or obligation to update these statements publicly as a result of new information, future events or otherwise, except as required by law.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260204322066/en/
Investor Relations Contact:

Sherri Scribner

Vice President, Strategy and Investor Relations

203-265-8820

IR@amphenol.com


Original: Amphenol Announces Board Succession Plan

The split went into effect this morning

Are you guessing?

There was only ONE (so far?) site that listed this stock as a % decliner: https://markets.businessinsider.com/index/market-movers/s&p_500

Split 2 or 1

Anybody know the story here? .......Thanks!!!

APH new 52 week high

APH new 52 week high

No doubt. Nice Hit!

APH new 52 week high

Amphenol Interconnect Products Corp., suspected sabotage of LMC parts.

First 19 recalled from a faulty connector and now a faulty washer on the brake caliper.

3 strikes and you're out is the message to Amphenol Interconnect Products Corp from shareholders of LMC.

Two different products in a month.

With Rivian Recall of 200,000 and Ford recalling 1.5 million EV's makes one wonder if EV's are under attack by big oil.

$APH $68.64

News: $APH Why Amphenol Stock Climbed 10.2% Last Month

Shares of Amphenol   (NYSE: APH) climbed 10.2% in September, according to data from  S&P Global Market Intelligence . The stock benefited from momentum for the broader market and the publication of research reports that boded well for the company's outlook in industrial sensors.&...

Find out more APH - Why Amphenol Stock Climbed 10.2% Last Month

BlindJohn - known ya since back in 2014 when all this took root! Remember You from SL especially. I hope all is well and that you have prospered SUPREMELY on all of your plays in this sector!

Take care! Remember "Blind Melon Chitlin" from Cheech and Chong LOL:




APH has been so good to us....and as a global player APH will be a force to be reckoned with my friend. Been holding BIG here all the way along. Take care and all best wishes for the New Year!
Gk

Aphria continues to be a BEAST almost everyday lately!!!
+.19/+.2.7% to finish the day at $7.31!!!
Looking for many more green days in advance of quarterly results on Fri Oct 13th
Over 5 consecutive quarters of positive earnings and #6 next week IMO!
Aphria top 50 TSX stocks of 2017 to own and top 30 IHUB boards of 2017 to be on with 0% negative posts and 100% positive posts.
$8 holla definately around the corner... Maybe before quarterly results if not definately after quarterly results with pps $8+
Glta
$APH$

APH finished the week GREEN!! UP +.26/+3.8% with a closing pps of $7.12!!
This is a 5 month high!!... And expect many more green days ahead of next earnings report in several weeks.
APH had 5 consecutive quarters of exceptional earnings and continue higher growth each quarter,,,, expecting between $8-$9+ after financials IMO and near 10+ by years end..
With legalization taking place in Canada around the second week of July 2018 I expect IMO a pps around $14+
Glta
$APH$

APH finished the day +.14/+2.1% to close at $6.81!!!
Looking good into financials coming up in October.
APH has had at least the past 5 quarters-record quarter$ and this quarter coming up will be no different IMO.
With legalization in Canada happening around the second week in July 2018 I expect pps to be in excess of $14+ by then,,, an easy double from here.
Glta
$APH$

APH up +.38 +6.3% to close the day at $6.38!! MJ sector is currently booming and lots of very green days ahead IMO especially in advance of Canada legalizing MJ by JULY 1st 2018!!
Glta
$APH$

APH> Due for a run any day now!!! Someone has been quietly accumulating in the $5.90-$6 range for many days now.
$APH$

Lol 2$

APH what a BEAST!!! Gap up tomorrow first thing then BOOM BOOM!!!
$APH$

EBITDA increases 181% in the quarter, exceeding $2.8 million

Cash costs to produce dried cannabis per gram decreases 35% from prior quarter

LEAMINGTON, ONTARIO – July 12, 2017 – Aphria Inc. (“Aphria” or the “Company”) (TSX: APH or USOTCQB: APHQF) today reported its results, for the fourth quarter and year ended May 31, 2017. All amounts are expressed in Canadian dollars.



Operating Highlights

• Seventh consecutive quarter of positive EBITDA. $2.8 million in EBITDA in the quarter, a 181% increase from the prior quarter, and $6.1 million for the year, a 962% increase year-over-year.

• Increased our annual production capacity expectations for Part II (to 9,000 kgs), Part III (to 30,000 kgs) & to Part IV (100,000 kgs) expansion projects.

• Received Health Canada approval for our Part II expansion. First harvest in the new expansion will occur in the middle of July. First sale, from the plants grown in the expansion, is expected in mid-August 2017 (late in Q1).

• Improved “all-in” costs to produce dried cannabis per gram from $2.23 to $1.67 in the quarter, a decrease of 25%.

• Improved cash costs to produce dried cannabis per gram from $1.73 to $1.11 in the quarter, a decrease of 36%, based on Aphria’s definition. Some of our competitors are using a definition different from Aphria’s for cash costs to produce. Applying their definition to our results, Aphria’s cash cost to produce per gram decreased from $1.42 to $0.79, a decrease of 44%.

• Exercised our conversion rights on the unsecured convertible debentures of SecureCom Mobile Inc.(“SecureCom”) in exchange for 4,000,000 shares and exercised our warrant, purchasing an additional 4,000,000 shares @ $0.08 per share bringing our total investment in SecureCom to 8,000,000 shares at a cost of $520,000. As at May 31, 2017, the fair value of the SecureCom shares was $1,664,000.

• Licensed the use of the Aphria Know-How System, as further detailed in the MD&A being filed concurrently with this release, to DFMMJ Investments, Ltd. (“DFMMJ”), in exchange for 192,400,000 shares in DFMMJ.

• Invested approximately $25 million in DFMMJ, which DFMMJ used, along with other monies raised via a private placement, to acquire all or substantially all of the assets of Chestnut Hill Tree Farm LLC, in exchange for in excess of 120,000,000 shares of DFMMJ, in addition to our existing DFMMJ shares.

• Received final approval to list on the Toronto Stock Exchange (“TSX”). Shares commenced trading on the TSX and were delisted from the TSX-Venture Exchange on March 22, 2017.

• Closed May bought deal and debt financing raising over $105 million in additional proceeds to fully fund our Part IV expansion project, fully fund our working capital needs after completion of the expansion project and raised funds for additional strategic investments.

“We capped off another exceptional year at Aphria, with increased earnings and lowered all-in production cash costs that provides us with a considerable competitive advantage,” said Vic Neufeld, Chief Executive Officer, Aphria. “We increased our capacity expectations, continued to license the use of the Aphria Know-How System to expand our proven operational expertise, made progress on our expansion into the US market – all while maintaining our commitment to delivering clean and safe cannabis. The investments and progress we made in 2017 have positioned Aphria for continued profitable growth, in both the short and long term.”

“As the medical marijuana industry rapidly expands, we believe there is a need to establish a consistent, responsible and transparent definition for licensed producers to calculate their costs to produce dried cannabis per gram. To ensure an accurate peer to peer comparison of this important metric, we are proposing the establishment of an industry standard definition for costs that includes all costs related to the production of cannabis, including quality control costs.”

Financial highlights

For the seventh consecutive quarter, the Company reported positive EBITDA. In the quarter, the Company reported $2.8 million in EBITDA, a 181% increase over the prior quarter and for the year ended May 31, 2017, reported $6.1 million in EBITDA, a 961% increase over the prior year. The Company remains committed to the responsible use of our shareholders’ investment in Aphria. The Company continues to invest in its recreational brand, continues to proceed diligently on its capital investment plans and continues to explore other opportunities to increase shareholder value, while ensuring appropriate liquidity risk mitigation strategies are in place.
Revenue for the three months ended May 31, 2017 was $5,717,866, representing a 11.7% increase over the prior quarter’s revenue of $5,188,516, in a quarter in which the Company was capacity constrained. The Company’s exceptional March and May harvests, along with its inventory levels, allowed the Company to sell more than its expected quarterly production of 650 kgs. Cannabis oil sales, as a percentage of all revenue, continued to grow in the quarter, increasing to 32% of revenue.

For the year ended May 31, 2017, revenue was $20,438,483 versus $8,433,929 in the year ended May 31, 2016, an increase of 142%.

Adjusted gross profit for the fourth quarter was $4,902,960 with an adjusted gross margin of 85.7%, generated from both retail and wholesale shipments of medical cannabis. The increase in the adjusted gross margin from the prior quarter is consistent with the increase in revenues combined with improved cost structures.

Adjusted gross profit for the year was $15,853,608, with an adjusted gross margin of 77.6%.

During the quarter, our “all-in” costs of dried cannabis per gram decreased from $2.23 to $1.67. The decrease largely related to improved growing techniques and better cooperation from Mother Nature. Similarly, our cash costs of dried cannabis per gram decreased from $1.73 to $1.11, using Aphria’s standard definition.

While the Company believes strongly in its definition of cash costs to produce dried cannabis per gram, certain of its publicly traded competitors are disclosing a similarly titled metric but for which they are using a different definition of cash costs. The primary differences between Aphria’s definition and certain competitors’ definition is that Aphria’s definition includes the costs related to indirect labour expenses and quality control costs. Aphria believes that both of these expenses should be included in any cash cost calculation. However, for the sole purpose of presenting a figure which is comparable to this other definition, we re-calculated our cash costs to produce dried cannabis per gram by deducting so-called post production costs from our cash cost to produce dried cannabis and divided that sum by gram equivalents sold in the quarter. Using this definition of cash costs to produce dried cannabis, Aphria’s fourth quarter figure is $0.79 per gram.

Net loss for the three months ended May 31, 2017 was $2,592,742 or $0.02 per share as opposed to a net income of $1,302,164 or $0.02 per share in the same quarter in the previous year and an income before tax of $4,950,250 or $0.04 per share in the previous quarter. The decrease in net income for Aphria in the quarter is directly related to the more than $5.5 million net loss on the Company’s strategic investments in the quarter.

Net income for the year ended May 31, 2017 was $4,198,455 or $0.04 per share versus net income of $397,961 or $0.01 in the prior year. Included in the net income for the 2017 year was a gain on the Company’s investment portfolio of almost $3.6 million and a write-off of the Company’s intangible asset, related to its CannWay brand, of $3.5 million.

EBITDA for the fourth quarter was $2,826,667, compared to an EBITDA of $520,685 in the same period of the prior year and EBITDA of $1,005,516 in the previous quarter.

EBITDA for the year ended May 31, 2017 was $6,082,546 compared to EBITDA of $572,888 in the prior year.

We have A Good Thing Growing.

1 – In this press release, reference is made to “all-in” costs to produce dried cannabis per gram, cash costs to produce dried cannabis, cash costs to produce dried cannabis per gram, adjusted gross profit, adjusted gross margin and EBITDA, which are not measures of financial performance under International Financial Reporting Standards. Definitions for all terms above can be found in the Company’s May 31, 2017 Management’s Discussion and Analysis, filed on SEDAR.

About Aphria
Aphria Inc., one of Canada’s lowest cost producers, produces, supplies and sells medical cannabis. Located in Leamington, Ontario, the greenhouse capital of Canada. Aphria is truly powered by sunlight, allowing for the most natural growing conditions available. We are committed to providing pharma-grade medical cannabis, superior patient care while balancing patient economics and returns to shareholders. We are the first public licenced producer to report positive cash flow from operations and the first to report positive earnings in consecutive quarters.

For more information, visit www.aphria.com.

For further information please contact:
Nina Godard
Edelman
nina.godard@edelman.com
416-455-6324

Vic Neufeld
President & CEO
1-844-427-4742

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS: Certain information in this news release constitutes forward-looking statements under applicable securities laws. Any statements that are contained in this news release that are not statements of historical fact may be deemed to be forward-looking statements. Forward-looking statements are often identified by terms such as “may”, “should”, “anticipate”, “expect”, “potential”, “believe”, “intend” or the negative of these terms and similar expressions. Forward-looking statements in this news release include, but are not limited to, statements with respect to internal expectations, estimated margins, expectations for future growing capacity and costs, the completion of any capital project or expansions, any commentary related to the legalization of cannabis and the timing related thereto, expectations of Health Canada approvals and expectations with respect to future production costs. Forward-looking statements necessarily involve known and unknown risks, including, without limitation, risks associated with general economic conditions; adverse industry events; marketing costs; loss of markets; future legislative and regulatory developments involving medical cannabis or adult use of cannabis; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favourable terms; the medical cannabis industry in Canada generally, income tax and regulatory matters; the ability of Aphria to implement its business strategies; competition; crop failure; currency and interest rate fluctuations and other risks.

Readers are cautioned that the foregoing list is not exhaustive. Readers are further cautioned not to place undue reliance on forward-looking statements as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement.

$APH$

Keep rising APH. Need you to be at $2.00 when $sprw f gets license so $SPrwf can hit $1.00 land

Boom

Why the plummet today?

Looks like Aphria got another license. I bet that's why they suspended trading.

The company itself put a halt.. That is perfectly normal here in Canada.. Some kind of news are coming that is why

Seems this stock has been halted... Not that it traded anyway.

1.00 would be 5200% profit and you would need to sell here and stay the course right?

THIS WILL MOVE BACK TO A-$1.00-NOW-AT-$52.33-HOLDING-FOR-100%-PROFIT-HERE-NO-BRAINER

Amphenol Corp. Announces Second Quarter 2012 Dividend Payment and Quarterly D...
Reuters Key Development - Apr 26, 2012

http://stocks.us.reuters.com/stocks/keyDevelopments.asp?rpc=66&symbol=APH×tamp=20120426120000

~ Wednesday! $APH ~ Q1 Earnings posted, pending or coming soon! In Charts and Links Below!

~ $APH ~ Earnings expected on Wednesday *
Want more like this? Search Keyword: MACMONEY >>> http://tinyurl.com/MACMONEY <<<
One or more of many earnings sites has alerted this security has or will be posting earnings on or around the day of this message.








http://stockcharts.com/h-sc/ui?s=APH&p=D&b=3&g=0&id=p88783918276&a=237480049




http://stockcharts.com/h-sc/ui?s=APH&p=W&b=3&g=0&id=p54550695994



~ Google Finance: http://www.google.com/finance?q=APH
~ Google Fin Options: hhttp://www.google.com/finance/option_chain?q=APH#
~ Yahoo! Finance ~ Stats: http://finance.yahoo.com/q/ks?s=APH+Key+Statistics
~ Yahoo! Finance ~ Profile: http://finance.yahoo.com/q/pr?s=APH
Finviz: http://finviz.com/quote.ashx?t=APH
~ BusyStock: http://busystock.com/i.php?s=APH&v=2


<<<<<< http://www.earningswhispers.com/stocks.asp?symbol=APH >>>>>>



http://investorshub.advfn.com/boards/post_prvt.aspx?user=251916

*If the earnings date is in error please ignore error. I do my best.

Amphenol Corporation (Amphenol) is a designer, manufacturer and marketer of electrical, electronic and fiber optic connectors, interconnect systems and coaxial and high-speed specialty cable. Amphenol designs and manufactures connectors and interconnect systems, which are used primarily to conduct electrical and optical signals for a range of electronic applications. It has developed a range of connector and interconnect products for information technology and communications equipment applications, including the converging voice, video and data communications markets. The Company offers a range of interconnect products for factory automation and motion control systems, machine tools, instrumentation and medical systems, mass transportation applications and automotive safety systems and a diverse range of on-board electronics. In addition, Amphenol is a supplier of high performance, military-specification, circular environmental connectors.

http://www.google.com/finance?q=APH